📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. (2021)

First Author: Butler CC

Attributed to: Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00310-6

PubMed Identifier: 34329624

Publication URI: http://europepmc.org/abstract/MED/34329624

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Respiratory medicine

Issue: 9

ISSN: 2213-2600